Status:
RECRUITING
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Myofascial Trigger Points
Cervicogenic Headache
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chronic cervicogenic headache is a common disease in China, with a high incidence among the elderly, and has a significant impact on patients' quality of life. Currently, both domestic and internation...
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with cervicogenic headache by at least two pain specialists or neurologists;
- Disease duration of at least 3 months;
- Age between 18 and 65 years;
- Numerical Rating Scale (NRS) score ≥ 3 despite conservative pharmacological treatment;
- Signed informed consent form.
Exclusion Criteria:
- History of allergy to trial medications such as corticosteroids;
- Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;
- Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;
- Inability to use pain assessment scales;
- Presence of local or systemic infection;
- Pregnant or lactating patients.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
1036 Patients enrolled
Trial Details
Trial ID
NCT07347730
Start Date
December 1 2025
End Date
June 1 2027
Last Update
January 16 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070